Financial Incentives + Communication Training for HPV Vaccine Uptake
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
Will I have to stop taking my current medications?
The trial does not specify whether participants need to stop taking their current medications. However, since the trial involves clinics and their staff rather than individual patients, it is unlikely that personal medication changes are required.
Is communication training and financial incentives for HPV vaccine uptake safe for humans?
How does the treatment of financial incentives and communication training for HPV vaccine uptake differ from other treatments?
This treatment is unique because it combines financial incentives with communication training to encourage HPV vaccine uptake, focusing on motivating both healthcare providers and patients through economic rewards and improved communication skills, rather than relying solely on medical or pharmaceutical interventions.14678
What data supports the effectiveness of the treatment involving communication training and financial incentives for HPV vaccine uptake?
Research shows that communication skills training can improve patient satisfaction and compliance with treatment, which suggests it might help increase HPV vaccine uptake. Additionally, effective communication has been linked to better treatment outcomes, indicating that training healthcare providers in communication could positively impact vaccine acceptance.910111213
Who Is on the Research Team?
Justin G Trogdon, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for pediatric or family medicine clinics in North Carolina with less than a 72% HPV vaccine initiation rate and at least 50 patients aged 9-12. Clinics must have at least two providers offering the HPV vaccine and no recent financial incentives or communication training aimed at increasing vaccination rates.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training and Intervention
Clinics receive communication training and some receive a financial incentive program with monthly data feedback
Follow-up
Participants are monitored for changes in HPV vaccination rates
What Are the Treatments Tested in This Trial?
Interventions
- Communication training
- Financial Incentive
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator